Patents by Inventor Baoru Wang

Baoru Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody or antibody fragment capable of binding to lung-specific X protein and use thereof
    Patent number: 10919978
    Abstract: The present application provides an antibody or antibody fragment capable of binding to a lung-specific X protein and being used to treat a tumor, and a use thereof. The antibody or antibody fragment includes heavy chain CDRs having amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 and light chain CDRs having amino acid sequences of SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6. Alternatively, the antibody or antibody fragment includes heavy chain CDRs having amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 7, and SEQ ID NO: 3 and light chain CDRs having amino acid sequences of SEQ ID NO: 8, SEQ ID NO: 5, and SEQ ID NO: 6. The antibody is a chimeric antibody.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: February 16, 2021
    Assignee: IMMUNOPHARMACEUTIC INSTITUTE OF HEFEI RUIDA CO., LTD.
    Inventors: Zhigang Tian, Haiming Wei, Xiaohu Zheng, Rui Sun, Weihua Xiao, Dan Liu, Baoru Wang
  • ANTIBODY OR ANTIBODY FRAGMENT CAPABLE OF BINDING TO LUNG-SPECIFIC X PROTEIN AND USE THEREOF
    Publication number: 20190322758
    Abstract: The present application provides an antibody or antibody fragment capable of binding to a lung-specific X protein and being used to treat a tumor, and a use thereof. The antibody or antibody fragment includes heavy chain CDRs having amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3 and light chain CDRs having amino acid sequences of SEQ ID NO: 4, SEQ ID NO: 5, and SEQ ID NO: 6. Alternatively, the antibody or antibody fragment includes heavy chain CDRs having amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 7, and SEQ ID NO: 3 and light chain CDRs having amino acid sequences of SEQ ID NO: 8, SEQ ID NO: 5, and SEQ ID NO: 6. The antibody is a chimeric antibody.
    Type: Application
    Filed: May 25, 2017
    Publication date: October 24, 2019
    Applicant: Immunopharmaceutic Institute of Hefei Ruida Co., Ltd.
    Inventors: Zhigang Tian, Haiming Wei, Xiaohu Zheng, Rui Sun, Weihua Xiao, Dan Liu, Baoru Wang